Table II.
Wave frequency, mHz | |||
---|---|---|---|
Group | Time at which measurement taken | α | β |
GV20 | |||
Rat 1 | Pretreatment | 10.1936 | 32.6975 |
Retained needle | 12.2616a | 25.4447a | |
Rat 2 | Pretreatment | 10.5781 | 32.6994 |
Retained needle | 12.2057a | 23.0262a | |
Rat 3 | Pretreatment | 10.2926 | 32.9251 |
Retained needle | 12.3499a | 22.8959a | |
Rat 4 | Pretreatment | 9.4188 | 31.1205 |
Retained needle | 12.2616a | 22.9197a | |
Sham acupoint | |||
Rat 1 | Pretreatment | 10.5558 | 31.9311 |
Retained needle | 10.7676b | 31.5172b | |
Rat 2 | Pretreatment | 10.8959 | 29.7769 |
Retained needle | 10.4773b | 29.3446b | |
Rat 3 | Pretreatment | 10.6971 | 35.6291 |
Retained needle | 10.2877b | 36.3446b | |
Rat 4 | Pretreatment | 9.9528 | 33.2436 |
Retained needle | 9.6955b | 33.4247b |
P<0.05 vs. the corresponding pretreatment
P<0.05 vs. the corresponding retained needle in the GV20 group.